(Q35817147)

10 August 2017

Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to amphotericin B and pentamidine (English)

1 reference

10 August 2017

visceral leishmaniasis

1 reference

1 reference

H W Murray

1

1 reference

10 August 2017

J Hariprashad

series ordinal

2

1 reference

10 August 2017

R E Fichtl

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

Antimicrobial Agents and Chemotherapy

10 August 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 August 2017

37

1 reference

10 August 2017

7

1 reference

10 August 2017

1504-1505

1 reference

An in Vitro Model for Investigation of Chemotherapeutic Agents in Leishmaniasis

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Visceral leishmaniasis in immunocompromised hosts

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Liposomal amphotericin B in the treatment of visceral leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Liposomal amphotericin B in drug-resistant visceral leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Amphotericin versus pentamidine in antimony-unresponsive kala-azar

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

Comparison of Regimes of Treatment of Antimony-Resistant Kala-Azar Patients: A Randomized Study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188002

The experimental chemotherapy of leishmaniasis, IV. The development of a rodent model for visceral infection

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8363382

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8363382

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.37.7.1504

1 reference

10 August 2017

1 reference

10 August 2017

1 reference